EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands (2009)

These guidelines deal with the indications, assessment, processing, interpretation and reporting of dopamine D2 receptor SPECT and PET studies using the commercially available radiopharmaceuticals [123I]-IBZM and [123I]-epidepride, as well as [11C]-raclopride, [18F]fallypride and DMFP.